摘要:
A benzazepine derivative which is a compound of formula (I): ##STR1## in which each of m and n denotes the number 1, oreach of m and n denotes the number 2, orm denotes the number 3 and n denotes the number 1; and R denotes hydrogen or a group of formula --Z--R' in which Z denotes a --CO-- or --CH.sub.2 -- group and R' denotes a phenyl group which is unsubtituted or substituted with from one to three substituents selected from halogen atoms, linear or branch (C.sub.1 -C.sub.3) alkyl groups and linear or branched (C.sub.1 -C.sub.3) alkoxy groups, or a pharmacologically acceptable acid addition salt.
摘要:
[(1-Arylpyrrolidin-2-yl)methyl]piperazine compounds corresponding to the formula ##STR1## in which Z denotes a group of formula N-R.sub.1 in which R.sub.1 is either a hydrogen atom or a C.sub.1-3 alkyl group or a group of formula Ar--C.sub.n H.sub.2n in which n denotes 0, 1 or 2 and Ar denotes a phenyl group optionally substituted by one or more halogen atoms and/or C.sub.1-3 alkyl or C.sub.1-3 alkoxy radicals, or a group of formula COR.sub.2 in which R.sub.2 denotes the CH.sub.3, C.sub.6 H.sub.5, CH.sub.2 C.sub.6 H.sub.5 or OC.sub.2 H.sub.5 group and their salts of addition to pharmaceutically acceptable acids. The compounds are useful for the treatment of neurological disorders.
摘要翻译:对应于式(I)的[(1-芳基吡咯烷-2-基)甲基]哌嗪化合物,其中Z表示式为N-R 1的基团,其中R 1为氢原子或C 1-3烷基 或其中n表示0,1或2且Ar表示任选被一个或多个卤素原子和/或C 1-3烷基或C 1-3烷氧基取代的苯基的式Ar-C n H 2n的基团,或式 COR2,其中R2表示CH 3,C 6 H 5,CH 2 C 6 H 5或OC 2 H 5基团,以及它们与药学上可接受的酸的加成盐。 该化合物可用于治疗神经障碍。
摘要:
A compound which is a pyrido[3,4-b]derivative of formula (I) ##STR1## in which R is a hydrogen atom or an alkyl carbonyl, arylalkylcarbonyl or arylcarbonyl group of formula COR.sub.1 wherein R.sub.1 is a C.sub.1 -C.sub.6 alkyl group, a benzyl group or a phenyl group unsubstituted or substituted with 1 to 3 substituents chosen from halogen atoms and trifluoromethyl, C.sub.1 -C.sub.3 alkyl and C.sub.1 -C.sub.3 alkoxy groups or R is an alkoxycarbonyl or benzyloxycarbonyl group of formula COOR.sub.2 wherein R.sub.2 is a C.sub.1 -C.sub.6 alkyl group or a benzyl group, or R is a substituted aminocarbonyl group of formula CONHR.sub.3 wherein R.sub.3 is a C.sub.1 -C.sub.6 alkyl group or a phenyl group, or R is an arylsulphonyl group of formula SO.sub.2 R.sub.4 wherein R.sub.4 is a phenyl group, or a pharmacologically acceptable acid addition salt thereof useful for treating hypertension, depressive state or anxiety state.
摘要翻译:化合物,其是式(I)的吡啶并[3,4-b]衍生物,其中R是氢原子或式COR1的烷基羰基,芳基烷基羰基或芳基羰基,其中R1是C1- C6烷基,苄基或未取代的或被1至3个选自卤素原子和三氟甲基,C1-C3烷基和C1-C3烷氧基的取代基取代的苯基,或者R是式COOR2的烷氧基羰基或苄氧基羰基,其中R2是 C 1 -C 6烷基或苄基,或R是式CONHR 3的取代的氨基羰基,其中R 3是C 1 -C 6烷基或苯基,或R是式SO 2 R 4的芳基磺酰基,其中R 4是苯基 ,或其可用于治疗高血压,抑郁状态或焦虑状态的药理学上可接受的酸加成盐。
摘要:
Imidazoline derivatives of formula (I) ##STR1## in which n is 1 or 2, R is hydrogen, C.sub.1 -C.sub.3 alkyl or allyl group, and X is hydrogen, halogen atom, methyl or methoxy, in the form of enantiomers or mixtures thereof, and their pharmaceutically acceptable acid addition salts are useful as .alpha..sub.2 -antagonists.
摘要:
2-(4,5-Dihydro-1H-imidazol-2-yl)-1,2,4,5-tetrahydropyrrolo[3,2,1-hi]indole derivatives and their pharmaceutically acceptable salts are useful an antidiabetic agents.
摘要:
Pyrrolo[3,2,1-hi]indole derivatives, in the form of racemates or optically active isomers, of formula (I) ##STR1## in which R is a hydrogen atom or C.sub.1 -C.sub.4 alkyl and R.sub.1 and R.sub.2, which may be the same or different, are hydrogen, halogen or C.sub.1 -C.sub.4 alkyl and their pharmaceutically acceptable acid addition salts are useful as .alpha..sub.2 -antagonists.
摘要:
The invention relates to thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives of general formula (I) wherein Het is thiazole, oxazole, imidazole, isoxazole or isoxazoline, n is an integer from 0 to 6, A is notably selected from various optionally substituted aromatic radicals, B is notably hydrogen, alkyl or phenyl, R1 and R2 are notably independently hydrogen, alkyl or cycloalkyl and Ω is —NR46R47 or —OR48, R46 and R47 are notably independently hydrogen, alkyl, cycloalkyl or —(CH2)k—COOR51, R51 is notably alkyl or haloalkyl and R48 is notably hydrogen or alkyl.These compounds have advantageous pharmacological properties which allow their use in therapeutics, notably for treating neurodegenerative disorders or pain.
摘要:
The present invention relates to the novel triaminopyrimidine derivatives of formula (I) in which R1, R2, W, R3, R4, and R5 are variable groups. These products have a Cdc25-phosphatase-inhibiting activity. The invention also relates to a process for synthesizing these compounds and also to therapeutic compositions containing these products and to the use thereof as medicaments.
摘要:
The invention concerns novel imidazole derivatives of general formula (I), wherein Z′ and Z represent different variable groups. Said products have an antitumoral activity. The invention also concerns pharmaceutical compositions containing said products and their use for preparing antitumoral medicine.
摘要:
Compositions for treating cancer comprising an amount of a camptothecin with a 7-ring β-hydroxy lactone ring of the formula wherein the substituents are defined as in the specification sufficient to treat cancer.